A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.
The registrational trial will include 212 patients who are newly diagnosed with advanced head and neck cancer.
Relationship between PD-L1 expression and the number of biopsy specimens in advanced gastric cancer.
Genomic landscape study of esophago-gastric adenocarcinoma (EGAC) in young patients under the age of 30 years. Relationship between the number of biopsy specimens and PD-L1 positivity.
Researchers from Tianjin University have published data regarding development and preclinical characterization of a new anti-PD-L1/CD40 bispecific antibody (BsAb), BA-4415, designed to activate CD40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback